Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults.

Jacobson, J M; Lowy, I; Fletcher, C V; O'Neill, T J; Tran, D N; Ketas, T J; Trkola, A; Klotman, M E; Maddon, P J; Olson, W C; Israel, R J

Jacobson, J M; Lowy, I; Fletcher, C V; O'Neill, T J; Tran, D N; Ketas, T J; Trkola, A; Klotman, M E; Maddon, P J; Olson, W C; Israel, R J.

Affiliation

Jacobson JM; Mount Sinai Medical Center, New York, NY 10029-6574, USA. jeffrey.jacobson@mssm.edu

J Infect Dis ; 182(1): 326-9, 2000 Jul.

Article in En | MEDLINE | ID: mdl-10882617

Subject(s)

Anti-HIV Agents/administration & dosage; CD4 Immunoadhesins/administration & dosage; HIV Infections/drug therapy; HIV-1/drug effects; Anti-HIV Agents/adverse effects; Anti-HIV Agents/blood; Anti-HIV Agents/therapeutic use; CD4 Immunoadhesins/adverse effects; CD4 Immunoadhesins/blood; CD4 Immunoadhesins/therapeutic use; HIV Infections/blood; HIV Infections/immunology; HIV Infections/virology; HIV-1/genetics; HIV-1/physiology; Humans; Infusions, Intravenous; RNA, Viral/blood; RNA, Viral/drug effects; Viral Load; Viremia/etiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / CD4 Immunoadhesins / Anti-HIV Agents Type of study: Etiology_studies Limits: Humans Language: En Journal: J Infect Dis Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links